TBS with 5% Nonfat Soy Milk
Cat No.: DCP-DMB05
Size: 100 mL, 500 mL & 1000 mL
Sterile; Ultrapure, Filtered 0.1-micron membrane TWICE and 0.04-micron membrane ONCE.
- World’s cleanest buffer for all cell and molecular biology experiments
Description:
TBS with 5% Nonfat Soy Milk is a specialized solution used primarily in Western blotting and other protein analysis techniques. Soy milk provides an alternative plant-based blocking agent for those avoiding animal products.Soymilk was found to have superior blocking efficacy compared to other blocking agents, including nonfat dry milk, in terms of achieving a higher signal-to-noise ratio [1]. Soymilk achieved effective blocking with very short blocking times, even as little as 10 seconds in some cases [1]. Soymilk is casein-free, biotin-free, and devoid of animal proteins [1]. This makes it advantageous in certain applications where these components might interfere. This can significantly reduce the overall time required for the Western blotting procedure.TBS helps maintain a stable pH, which is important for optimal antibody-antigen interactions and overall assay performance. TBS is recommended when using alkaline phosphatase (AP) conjugates or AP-based detection methods, as the phosphate in PBS can interfere with AP activity.
* The optimal concentration and blocking time may vary depending on the specific experimental conditions and antibodies used.
Usage consideration:
- Milk contains phosphatases that may interfere with phosphoprotein detection.
- Soymilk is casein-free, biotin-free, and devoid of animal proteins, which can be advantageous in certain applications.
Applications
- Block non-specific binding: The nonfat dry milk proteins occupy vacant binding sites on the membrane, reducing background noise and improving the signal-to-noise ratio in Western blots.
- Dilute antibodies: It serves as a medium for diluting primary and secondary antibodies used in immunoblotting procedures.
Advantages:
- Soymilk has been reported to have superior blocking efficacy compared to other blocking agents, including nonfat dry milk, in terms of higher signal-to-noise ratio.
- Soymilk achieved effective blocking with very short blocking times, even as little as 10 seconds in some cases.
- Soymilk performed better than nonfat dry milk on blots that were stripped for reuse.
- Preservation: ProClin 300 helps maintain the integrity of the solution, preventing microbial growth.
- Versatility: This formulation is compatible with a wide range of antibodies and target proteins
Composition:
| Ingredients |
Concentration |
| Nonfat Soy Milk |
5% |
| ProClin 300 |
0.05% |
| Tris-Base |
20 mM |
| Sodium Chloride |
150 mM |
Quality Control:
- Appearance: Clear, Colorless Liquid.
- pH: 7.4
- Sterility: Filtered 0.1 micron Twice and 0.04 micron once in a sterile environment.
- DNase activity: None was detected after incubation of plasmid DNA and this product for 18 hr at room temperature.
- RNase activity: No RNase activity was detected after incubation of ribosomal RNA and this product for 18 hr at room temperature.
Storage and Shelf Life:
- Storage: 4 ℃
- Shelf life: 1 year
CUSTOMIZATION: Please INQUIRE if other concentrations, additions of chemicals/compounds/proteins/supplements, different pH, and modifications are needed.
All DiagnoCine Precision Sterile buffers are filtered-sterilized with a 0.1-micron filtration two times and 0.04-micron filtration one time. Thus, mycoplasma contamination is prevented. The smallest size mycoplasma type can be about 0.2 microns.
* This product is manufactured under ISO 13485-certified and CE-approved facilities (Suppliers of DiagnoCine Precision). All final packaging, quality assurance, and testing are done at the DiagnoCine R&D and Quality Testing Center. All specific customization requests and assembly were accomplished at DiagnoCine Precision in Totowa, New Jersey, USA.
Reference:
[1] Galva, C., Gatto, C., & Milanick, M. (2012). Soymilk: an effective and inexpensive blocking agent for immunoblotting. Analytical biochemistry, 426(1), 22–23. https://doi.org/10.1016/j.ab.2012.03.028
